CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B903. A total of 2 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $462,000 | -33.4% | 105,300 | -42.6% | 0.00% | 0.0% |
| Q1 2016 | $694,000 | -66.2% | 183,500 | +40.0% | 0.00% | -50.0% |
| Q4 2015 | $2,056,000 | +135.8% | 131,100 | +58.5% | 0.00% | +100.0% |
| Q3 2015 | $872,000 | -63.8% | 82,700 | -13.4% | 0.00% | -50.0% |
| Q2 2015 | $2,409,000 | -20.0% | 95,500 | -11.6% | 0.00% | -33.3% |
| Q1 2015 | $3,010,000 | +25.8% | 108,000 | -17.6% | 0.00% | +50.0% |
| Q4 2014 | $2,393,000 | +76.7% | 131,100 | +25.5% | 0.00% | +100.0% |
| Q3 2014 | $1,354,000 | +11.6% | 104,500 | +40.6% | 0.00% | 0.0% |
| Q2 2014 | $1,213,000 | +0.7% | 74,300 | +8.9% | 0.00% | 0.0% |
| Q1 2014 | $1,205,000 | -42.4% | 68,200 | -21.1% | 0.00% | -66.7% |
| Q4 2013 | $2,092,000 | -48.3% | 86,400 | -24.3% | 0.00% | -50.0% |
| Q3 2013 | $4,043,000 | +479.2% | 114,100 | +155.3% | 0.01% | +500.0% |
| Q2 2013 | $698,000 | – | 44,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 156,600 | $633,000 | 0.01% |
| SIMPLEX TRADING, LLC | 121 | $1,000 | 0.00% |